Protective strategies to prevent trastuzumab-induced cardiotoxicity
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial;Earl;Lancet,2019
2. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1;Chang;J Am Coll Cardiol,2017
3. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial;Pivot;Lancet,2019
4. Meta-analysis of carvedilol for the prevention of anthracycline-induced cardiotoxicity;Kheiri;Am J Cardiol,2018
5. Randomized trial of lisinopril versus carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer;Guglin;J Am Coll Cardiol,2019
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods;Current Treatment Options in Oncology;2024-04-27
2. Research Progress on Flavonoids in Traditional Chinese Medicine to Counteract Cardiotoxicity Associated with Anti-Tumor Drugs;Reviews in Cardiovascular Medicine;2024-02-27
3. Palpitations in a Young Woman With Breast Cancer;JAMA Internal Medicine;2023-08-01
4. Therapeutic Potentials of Selected Antihypertensive Agents and Their Fixed-Dose Combinations Against Trastuzumab-Mediated Cardiotoxicity;Frontiers in Pharmacology;2021-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3